Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) announced Friday morning that EYLEA Injection demonstrated a significantly greater improvement in mean change in best-corrected visual acuity from baseline at 52 weeks compared to both Avastin and Lucentis in a comparative study. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) in last trading activity increased 8.49% to close at $369.64. Company weekly performance is 7.61% while its quarterly performance stands at 21.70%. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is 0.09% away from its 52 week high. Nektar Therapeutics (NASDAQ:NKTR)’s stock has been given a consensus recommendation of “Hold” by the eight analysts that are currently covering the stock, Analyst Ratings.Net reports on Oct. 13. On last trading day Nektar Therapeutics (NASDAQ:NKTR) fell -6.63% to close at $12.40. Its volatility for the week is 7.24% while volatility for the month is 4.70%. NKTR's sales growth for past 5 years was 10.50% and its EPS growth for past 5 years was -30.50%. Nektar Therapeutics (NASDAQ:NKTR) monthly performance is -7.19%. Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) and Citra Health Solutions announced a commercial partnership to make their respective solutions and services readily available to the other’s client base. On last trading day Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) fell -0.04% to close at $12.86. Its volatility for the week is 2.82% while volatility for the month is 2.60%. MDRX's sales growth for past 5 years was 20.10% and its EPS growth for past 5 years was -36.90%. Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) monthly performance is -10.85%. United Microelectronics Corporation (NYSE:UMC), a leading independent semiconductor foundry, will hold its quarterly conference call to discuss third quarter 2014 results on Wednesday, October 29, 2014, at 5:00 a.m. US Eastern Time. United Microelectronics Corporation (NYSE:UMC) has its institutional ownership stands at 5.60%. In last trading activity company's stock closed at $1.97. Schmitt Industries Inc. (NASDAQ:SMIT) posted its quarterly earnings results on Friday. The company reported $0.02 earnings per share for the quarter. The company had revenue of $3.05 million for the quarter, compared to the consensus estimate of $2.90 million. On Friday shares of Schmitt Industries, Inc. (NASDAQ:SMIT) closed at $2.99. Company's sales growth for last 5 years was 5.00%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
